SP3 and pancreatic neoplasm: We also observed that tumor growth in mice bearing L3.6pL pancreatic cancer cells depleted of Sp1 or Sp1, Sp3 and Sp4 (combined) was significantly lower than observed in studies using wild-type cells expressing these TFs (Figure 3E).